ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
+51.05%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$154M
AUM Growth
-$23.7M
Cap. Flow
-$63.5M
Cap. Flow %
-41.25%
Top 10 Hldgs %
62.2%
Holding
45
New
6
Increased
7
Reduced
17
Closed
11

Top Buys

1
OCUL icon
Ocular Therapeutix
OCUL
$12.1M
2
ELVN icon
Enliven Therapeutics
ELVN
$4.79M
3
APLT icon
Applied Therapeutics
APLT
$1.81M
4
CLDX icon
Celldex Therapeutics
CLDX
$1.66M
5
AGIO icon
Agios Pharmaceuticals
AGIO
$1.62M

Top Sells

1
RYZB
RayzeBio, Inc. Common Stock
RYZB
$23.5M
2
KURA icon
Kura Oncology
KURA
$13M
3
CBAY
Cymabay Therapeutics
CBAY
$11.6M
4
EYPT icon
EyePoint Pharmaceuticals
EYPT
$9.82M
5
PRAX icon
Praxis Precision Medicines
PRAX
$8.38M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ORIC icon
26
Oric Pharmaceuticals
ORIC
$1.06B
$1.43M 0.93%
+103,992
New +$1.43M
MREO
27
Mereo BioPharma
MREO
$282M
$1.31M 0.85%
+397,884
New +$1.31M
LYRA icon
28
Lyra Therapeutics
LYRA
$11.3M
$1.08M 0.7%
+3,466
New +$1.08M
LPTX icon
29
Leap Therapeutics
LPTX
$11.7M
$942K 0.61%
354,166
– –
RARE icon
30
Ultragenyx Pharmaceutical
RARE
$3.07B
$934K 0.61%
+20,000
New +$934K
ITCI
31
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$920K 0.6%
+13,300
New +$920K
CLRB icon
32
Cellectar Biosciences
CLRB
$15.9M
$571K 0.37%
4,783
-11,134
-70% -$1.33M
NUVB.WS icon
33
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
$27.5K 0.02%
90,832
– –
ANTX icon
34
AN2 Therapeutics
ANTX
$34.4M
– –
-132,000
Closed -$2.7M
APLS icon
35
Apellis Pharmaceuticals
APLS
$3.55B
– –
-76,100
Closed -$4.56M
ARGX icon
36
argenx
ARGX
$45.9B
– –
-2,400
Closed -$913K
AVXL icon
37
Anavex Life Sciences
AVXL
$807M
– –
0
– –
CNTA
38
Centessa Pharmaceuticals
CNTA
$2.11B
– –
-38,138
Closed -$304K
EYPT icon
39
EyePoint Pharmaceuticals
EYPT
$966M
– –
-425,128
Closed -$9.82M
FDMT icon
40
4D Molecular Therapeutics
FDMT
$340M
– –
-74,500
Closed -$1.51M
SWTX
41
DELISTED
SpringWorks Therapeutics
SWTX
– –
-10,000
Closed -$365K
TYRA icon
42
Tyra Biosciences
TYRA
$674M
– –
-8,867
Closed -$123K
VRNA
43
Verona Pharma
VRNA
$9.2B
– –
-19,000
Closed -$378K
CBAY
44
DELISTED
Cymabay Therapeutics
CBAY
– –
-492,155
Closed -$11.6M
RYZB
45
DELISTED
RayzeBio, Inc. Common Stock
RYZB
– –
-378,069
Closed -$23.5M
1
2